Actively Recruiting
A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT
Led by University of Rochester · Updated on 2026-01-26
40
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
Sponsors
U
University of Rochester
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Substance Use Disorders continue to increase across the United States with significant adverse effects resulting in more than $700 billion annually (NIDA, 2017) with high co-occurring rates of IPV. The negative consequences are devastating to families and society. This team has developed a digital, interactive platform, RITch®CBT for the convenience of participants' within their own home \& with out of session practice exercises. We propose to conduct a Phase I and II Study: UG3 (Phase I) and UH3 (Phase II) in collaboration with the FDA regarding ongoing feedback and regulatory processes. In Phase I, we propose a feasibility study, a randomized controlled trial to test the efficacy of RITch®CBT (n=20) among SUD-IPV diverse male clients entering addiction treatment comparing it to face to face 1:1 CBT (TAU, n=20). If efficacious, a Phase II (UH3, n=80) trial will be conducted to test the effectiveness of RITch®CBT among SUD-IPV compared to TAU (n=80) in reducing addiction and IPV.
CONDITIONS
Official Title
A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male participants aged 18 to 65 entering outpatient treatment
- Meet current DSM-V criteria for substance dependence with alcohol and/or stimulant use within 30 days before screening
- Report verbal aggression or conflict in a current intimate relationship within 30 days before screening
- Able to read English at a 6th grade level or higher
You will not qualify if you...
- Currently in withdrawal from substances and requiring detoxification
- Cognitive impairment with a mini mental state score below 25
- Psychomotor epilepsy causing impulsivity or rage symptoms
- Major medical complications such as head injury, trauma, or HIV dementia
- Currently receiving treatment for substance abuse or intimate partner violence elsewhere
- History of psychotic or bipolar disorder
- Currently suicidal or homicidal
- Severe violence involving punching, choking, or use of weapons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Strong Recovery - Part Of Strong Memorial Hospital
Rochester, New York, United States, 14623
Actively Recruiting
Research Team
C
Caroline J Easton, PhD
CONTACT
C
Cory Crane, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here